JAK1 inhibitors

摘要

The present invention relates to certain benzimidazole compounds, or pharmaceutically acceptable salts thereof, that inhibit Janus kinase 1 (JAK1), pharmaceutical compositions comprising the compounds, and methods of using the compounds to treat certain types of cancer.

主权项

1. A compound of Formula I: or a pharmaceutically acceptable salt thereof.